NewAmsterdam Pharma Company NV (NAMS) Q1 2025 Earnings

Feb 26Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.06
-0.77
-0.47
-0.18

Details

Expected EPS
-0.486193
Actual EPS
-0.93
Surprise EPS
-0.44
Surprise Percent
-91.28%

Description

⁨NewAmsterdam Pharma Company NV⁩ (⁦NAMS⁩) has reported earnings of ⁦-0.93⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts